Symposium 30: Deciphering functional specificity of the cannabinoid type 1 receptor in the brain: mechanistic insights and therapeutic implications
Tracks
Athina Hall
Monday, June 9, 2025 |
11:15 - 13:00 |
Athina Hall |
Speaker
Dr. Luigi Bellocchio
Researcher
Inserm U1215
Learning from CB1 Receptors in the Brain: Potentiation of Mitochondrial Activity as a Therapeutic Tool Against Pharmacological and Neurodegenerative Impairment of Cognition
Dr. Ana Bernal Chico
UPV/EHU, Achucarro Basque Center For Neuroscience and IIS Biobizkaia
Astrocyte Cannabinoid CB1 Receptor-Mediated Signaling During Autoimmune Inflammation: Mechanisms and Implications in Multiple Sclerosis
Prof. Antonio C Pagano Zottola
Bordeaux Institute of Oncology
Molecular mechanism of cannabinoids in glioblastoma: a new insight
Dr. Gianluca Lavanco
Assistant Professor
Università degli Studi di Palermo
Mitochondrial dysfunction in cognitive deficits: bridging prenatal THC exposure and bioenergetic pathways
Dr. Rosmara Infantino
Post-doc
University of Galway
Targeting sub-cellular CB1 specificity to enhance analgesic efficacy: characterization of the novel cannabinoid Δ9-Tetrahydrocannabiphorol
Organizer
Rosmara Infantino
Post-doc
University of Galway
Antonio C Pagano Zottola
Bordeaux Institute of Oncology
